Single-receptor GLP-1 agonists engage only the GLP-1 receptor, while Zepbound, as tirzepatide, adds the GIP receptor for a second incretin mechanism
Clinical trials show: Average weight loss of 1015% or more Improved insulin sensitivity Reduction in obesity-related conditions From an endocrinologists perspective, obesity is a chronic hormonal disease , and GLP-1 medications are toolsnot shortcutsfor managing it
This involves small incisions, which generally results in less pain, a lower risk of complications, and a faster return to your daily routineoften on the same day
However, without maintenance sessions, sun protection or proper skincare, your pigmentation will gradually return
It can also be found as an ingredient in cosmetics such as soaps, lotions, and serums